Two Sigma Investments’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,992
Closed -$71.7K 3750
2025
Q2
$71.7K Sell
24,992
-6,300
-20% -$16.6K ﹤0.01% 3033
2025
Q1
$84.5K Sell
31,292
-9,885
-24% -$37.1K ﹤0.01% 2984
2024
Q4
$97.2K Sell
41,177
-18,446
-31% -$49.1K ﹤0.01% 2971
2024
Q3
$141K Buy
59,623
+19,908
+50% +$43.8K ﹤0.01% 2851
2024
Q2
$77.4K Buy
+39,715
New +$135K ﹤0.01% 2849

Other funds holding GNLX

Two Sigma Investments's GNLX Position: Q3 2025 in Review

Two Sigma Investments sold out of Genelux (GNLX) in Q3 2025, closing a stake of 24,992 shares — an estimated $71.7K sold.

Two Sigma Investments first reported a position in GNLX in Q2 2024 and held it in 5 quarters. The position peaked at $141K in Q3 2024. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2025.

  • Two Sigma Investments reported no remaining Genelux position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 24,992 Genelux shares in Q3 2025, an estimated $71.7K.
  • Two Sigma Investments first reported a position in Genelux in Q2 2024 and held it in 5 quarters.
  • Two Sigma Investments's Genelux position peaked at $141K in Q3 2024.
  • 57 funds tracked by Wall St. Rank held Genelux as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.